Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Elevated levels of serum carcinoembryonic antigen (CEA) in patients with colorectal cancer (CRC) during follow-up suggest recurrence, which can be visualized by 18F-FDG PET/CT. Since the magnitude of CEA elevation reflects cancer volume, the ability of PET/CT to detect recurrence in patients with only mildly elevated CEA might be limited. However, the accuracy of PET/CT in detecting recurrence associated with elevated CEA has not been fully assessed. We retrospectively evaluated the diagnostic performance of 18F-FDG PET/CT postoperatively relative to CEA levels among patients with CRC.
We visually assessed 75 PET/CT evaluations of 57 postoperative patients with CEA >5.0 ng/ml. Tumor volumes were also determined using image analysis software. The final diagnosis was confirmed based on histopathological findings, or at least on 6 months of clinical follow-up.
Two lung cancers were excluded and we finally analyzed data from 73 of the 75 PET/CT evaluations. Recurrences were diagnosed in 54 (prevalence 74%). The sensitivity and specificity of PET/CT to detect recurrence was 50/54 (93%) and 14/19 (74%), respectively. The positive and negative predictive values were 91 and 78%, respectively, and the positive and negative likelihood ratios were 3.52 and 0.10, respectively. Values for the sensitivity of PET/CT were 88 and 95%, and those for specificity were 78 and 70%, at serum CEA concentrations of 5–10 and >10 ng/ml, respectively. Serum CEA (r = 0.500, p < 0.001) significantly correlated with cancer volumes.
The present findings showed that 18F-FDG PET/CT could accurately detect recurrent CRC irrespective of the elevated CEA concentration.
- Martin, EJ, Cooperman, M, Carey, L, Minton, J (1980) Sixty-second-look procedures indicated primarily by rise in serial carcinoembryonic antigen. J Surg Res 28: pp. 389-394 CrossRef
- Hine, K, Dykes, P (1984) Serum CEA testing in the post-operative surveillance of colorectal carcinoma. Br J Cancer 49: pp. 689-693
- Minton, J, Hoehn, J, Gerber, D, Horsley, J, Connolly, D, Salwan, F (1985) Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 55: pp. 1284-1290 CrossRef
- McCall, J, Black, R, Rich, C, Harvey, J, Baker, R, Watts, J (1994) The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 37: pp. 875-881 CrossRef
- Moertel, C, Fleming, T, Macdonald, J, Haller, D, Laurie, J, Tangen, C (1993) An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270: pp. 943-947 CrossRef
- Flanagan, F, Dehdashti, F, Ogunbiyi, O, Kodner, I, Siegel, B (1998) Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 227: pp. 319-323 CrossRef
- Flamen, P, Hoekstra, O, Homans, F, Cutsem, E, Maes, A, Stroobants, S (2001) Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). Eur J Cancer 37: pp. 862-869 CrossRef
- Huebner, R, Park, K, Shepherd, J, Schwimmer, J, Czernin, J, Phelps, M (2000) A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41: pp. 1177-1189
- Arnaud, J, Koehl, C, Adloff, M (1980) Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma. Dis Colon Rectum 23: pp. 141-144 CrossRef
- Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J Clin Oncol. 1996;14:2843–77.
- Choi, M, Lee, K, Chung, J, Lee, D, Jeong, J, Park, J (2005) Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer. Ann Nucl Med 19: pp. 123-129 CrossRef
- Okubo, M, Nishimura, Y, Nakamatsu, K, Okumura, M, Shibata, T, Kanamori, S (2008) Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system. Ann Nucl Med 22: pp. 579-586 CrossRef
- Dupont, W, Plummer, WJ (1990) Power and sample size calculations. A review and computer program. Control Clin Trials 11: pp. 116-128 CrossRef
- Findlay, M, Young, H, Cunningham, D, Iveson, A, Cronin, B, Hickish, T (1996) Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 14: pp. 700-708
- Gutman, F, Alberini, J, Wartski, M, Vilain, D, Le Stanc, E, Sarandi, F (2005) Incidental colonic focal lesions detected by FDG PET/CT. AJR Am J Roentgenol 185: pp. 495-500 CrossRef
- Konishi, J, Yamazaki, K, Tsukamoto, E, Tamaki, N, Onodera, Y, Otake, T (2003) Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 70: pp. 500-506 CrossRef
- Delbeke D, Martin W, Sandler M, Chapman W, Wright JJ, Pinson C. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg. 1998;133:510–5 (discussion 5–6).
- Hany, T, Steinert, H, Goerres, G, Buck, A, Schulthess, G (2002) PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 225: pp. 575-581 CrossRef
- Locker, G, Hamilton, S, Harris, J, Jessup, J, Kemeny, N, Macdonald, J (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24: pp. 5313-5327 CrossRef
- Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations
Annals of Nuclear Medicine
Volume 24, Issue 5 , pp 395-401
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Positron emission tomography (PET)
- Recurrent colorectal cancer
- Carcinoembryonic antigen (CEA)
- Tumor volume
- Industry Sectors
- Author Affiliations
- 1. Department of Radiology, Japan Self-Defense Forces Central Hospital, Tokyo, Japan
- 2. Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan
- 3. Department of Surgery, Tokyo Women’s Medical University, Tokyo, Japan